OncoDerm LLC – Trademark Portfolio

Entity Type: 16

OncoDerm LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ONCODERM, SENSIGROW, ORAL.LYTIC, and ONCODERM+ REPLENISH · RESTORE · REBUILD. The owner is based in New York, NY.

333 East 91st Street, #33A

New York, NY 10128

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OncoDerm LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (4 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does OncoDerm LLC have?

OncoDerm LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does OncoDerm LLC file in?

OncoDerm LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are OncoDerm LLC's most well-known trademarks?

OncoDerm LLC's registered trademark portfolio includes well-known marks such as ONCODERM, SENSIGROW, ORAL.LYTIC, and ONCODERM+ REPLENISH · RESTORE · REBUILD. These are among 4 currently registered trademarks in the portfolio.

What is OncoDerm LLC's trademark registration success rate?

OncoDerm LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.